We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$447M
AUM Growth
Cap. Flow
+$452M
Cap. Flow %
101.18%
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.4M
2
CELG
Celgene Corp
CELG
+$16.3M
3
AMGN icon
Amgen
AMGN
+$12.9M
4
LUV icon
Southwest Airlines
LUV
+$12.3M
5
AAPL icon
Apple
AAPL
+$10.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.33%
2 Consumer Staples 13.46%
3 Industrials 12.37%
4 Energy 9.97%
5 Technology 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
151
NVIDIA
NVDA
$4.77T
$531K 0.12%
+1,515,200
New +$523K
GIS icon
152
General Mills
GIS
$20.1B
$527K 0.12%
+10,866
New +$534K
JWN
153
DELISTED
Nordstrom
JWN
$527K 0.12%
+8,800
New +$510K
AIG icon
154
American International
AIG
$42.9B
$516K 0.12%
+11,540
New +$495K
CPB icon
155
Campbell Soup
CPB
$6.8B
$513K 0.11%
+11,453
New +$520K
TEX icon
156
Terex
TEX
$7.84B
$512K 0.11%
+19,450
New +$601K
IVW icon
157
iShares S&P 500 Growth ETF
IVW
$71.9B
$503K 0.11%
+23,932
New +$507K
APA icon
158
APA Corp
APA
$12.3B
$498K 0.11%
+5,950
New +$473K
BRK.B icon
159
Berkshire Hathaway Class B
BRK.B
$1.11T
$495K 0.11%
+4,420
New +$486K
FFIN icon
160
First Financial Bankshares
FFIN
$5.05B
$493K 0.11%
+35,404
New +$461K
KMI icon
161
Kinder Morgan
KMI
$70.3B
$475K 0.11%
+12,448
New +$483K
HAL icon
162
Halliburton
HAL
$26.1B
$472K 0.11%
+11,318
New +$473K
ADT
163
DELISTED
ADT Corp
ADT
$472K 0.11%
+11,845
New +$504K
COV
164
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$463K 0.1%
+8,311
New +$481K
UPS icon
165
United Parcel Service
UPS
$89.7B
$458K 0.1%
+5,300
New +$455K
ORCL icon
166
Oracle
ORCL
$346B
$455K 0.1%
+14,833
New +$492K
BMRN icon
167
BioMarin Pharmaceuticals
BMRN
$12B
$451K 0.1%
+8,100
New +$505K
DNDN
168
DELISTED
DENDREON CORPORATION
DNDN
$448K 0.1%
+108,700
New +$462K
CCL icon
169
Carnival Corporation Ltd
CCL
$38.7B
$446K 0.1%
+13,000
New +$440K
APU
170
DELISTED
AmeriGas Partners, L.P.
APU
$442K 0.1%
+8,950
New +$412K
PNC icon
171
PNC Financial Services
PNC
$100B
$433K 0.1%
+5,932
New +$411K
CMC icon
172
Commercial Metals
CMC
$7.8B
$431K 0.1%
+29,232
New +$430K
ELV icon
173
Elevance Health
ELV
$83.7B
$422K 0.09%
+5,153
New +$386K
APC
174
DELISTED
Anadarko Petroleum
APC
$417K 0.09%
+4,850
New +$417K
ZBH icon
175
Zimmer Biomet
ZBH
$18.5B
$409K 0.09%
+5,624
New +$421K

Similar funds

Gerald L. Ray & Associates's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.

  • Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
  • Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
  • Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.